Okyo Pharma finally spills the beans – interim results shocker
By Tom Winnifrith | Tuesday 3 January 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
As I pinged emails to and fro with the FCA about Okyo’s (OKYO) failure to publish proper results on Friday which should have led to a suspension at 7 AM but did not as the FCA is useless, Okyo has ‘fessed to the bad news.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.